Cytology and High-Risk Human Papillomavirus Testing Performance for Cervical Cancer Screening in Transmasculine Patients

Key Points

• The research aims to evaluate the effectiveness of cytology and hrHPV testing for predicting CIN2+ in transmasculine patients.
• Comparative analysis of cytology and hrHPV screening.
• Assessment of prevalence rates of CIN2+.
• Evaluation of cytology insufficiency rates.
• No significant difference in predictive ability for CIN2+ between tests.
• High rates of insufficient cytology in the transmasculine population.
• Suggests that primary hrHPV screening could reduce unnecessary pelvic exams.